Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau/APP mutant mice

BACKGROUND: Amyloid plaques and neurofibrillary tangles (NFTs) are the defining pathological hallmarks of Alzheimer’s disease (AD). Increasing the quantity of the O-linked N-acetylglucosamine (O-GlcNAc) post-translational modification of nuclear and cytoplasmic proteins slows neurodegeneration and b...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuzwa, Scott A, Shan, Xiaoyang, Jones, Bryan A, Zhao, Gang, Woodward, Melissa L, Li, Xiaojing, Zhu, Yanping, McEachern, Ernest J, Silverman, Michael A, Watson, Neil V, Gong, Cheng-Xin, Vocadlo, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232697/
https://www.ncbi.nlm.nih.gov/pubmed/25344697
http://dx.doi.org/10.1186/1750-1326-9-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232697/
https://www.ncbi.nlm.nih.gov/pubmed/25344697
http://dx.doi.org/10.1186/1750-1326-9-42

Ejemplares similares